Advertisement

Advertisement

ELUT Stock Latest News

Elutia receives $8M payment from Boston Scientific

The FlyElutia receives $8M payment from Boston Scientific

Elutia Inc. Earnings Call Highlights Funding, NXT Outlook

PremiumCompany Announcements

Elutia Inc. Earnings Call Highlights Funding, NXT Outlook

2M ago

Elutia Divests SimpliDerm to Refocus on NXT-41x

PremiumCompany Announcements

Elutia Divests SimpliDerm to Refocus on NXT-41x

2M ago

Cellution Biologics completes SimpliDerm acquisition from Elutia

PremiumThe Fly

Cellution Biologics completes SimpliDerm acquisition from Elutia

2M ago

ELUT Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

ELUT Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

Elutia Receives Nasdaq Notice on Listing Compliance Risk

PremiumCompany AnnouncementsElutia Receives Nasdaq Notice on Listing Compliance Risk

2M ago

Elutia Divests SimpliDerm Assets to Refocus Strategy

Company Announcements

Elutia Divests SimpliDerm Assets to Refocus Strategy

3M ago

Elutia to sell SimpliDerm business to Cellution Biologics for $11M

The Fly

Elutia to sell SimpliDerm business to Cellution Biologics for $11M

3M ago

Elutia Shareholders Approve Amended Incentive Plan and Governance

PremiumCompany Announcements

Elutia Shareholders Approve Amended Incentive Plan and Governance

4M ago

Aziyo Biologics Maps Risky Path to Breast Mesh Upside

PremiumCompany Announcements

Aziyo Biologics Maps Risky Path to Breast Mesh Upside

5M ago

Aziyo Biologics, Inc. Class A (ELUT) Q1 Earnings Cheat Sheet

PremiumPre-Earnings

Aziyo Biologics, Inc. Class A (ELUT) Q1 Earnings Cheat Sheet

5M ago

Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win

PremiumCompany Announcements

Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win

7M ago

Elutia announces grants of inducement awards

PremiumThe FlyElutia announces grants of inducement awards

7M ago

Aziyo Biologics Earnings Call: Cash, Risk and 41X

Company Announcements

Aziyo Biologics Earnings Call: Cash, Risk and 41X

7M ago

Elutia Adopts 2026 Inducement Equity Award Plan

Company Announcements

Elutia Adopts 2026 Inducement Equity Award Plan

8M ago

Aziyo Biologics, Inc. Class A (ELUT) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Aziyo Biologics, Inc. Class A (ELUT) Q4 Earnings Cheat Sheet

8M ago

Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status

PremiumCompany Announcements

Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status

8M ago

Elutia regains compliance with Nasdaq listing requirements

PremiumThe Fly

Elutia regains compliance with Nasdaq listing requirements

8M ago

Elutia appoints Ligotti as Chief Commercial Officer

PremiumThe Fly

Elutia appoints Ligotti as Chief Commercial Officer

8M ago

Elutia reports preliminary Q4 revenue $3.3M

PremiumThe FlyElutia reports preliminary Q4 revenue $3.3M

9M ago

Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing

Company Announcements

Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing

10M ago

Elutia management to meet with Lake Street

The Fly

Elutia management to meet with Lake Street

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >